CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,487
- in 1 filing, $122K under 10b5-1 plans
Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-15 | Hirsch Andrew President & CEO | Option exercise | +20,400 | 1,083,991 | ||
| 2026-02-15 | Hirsch Andrew President & CEO | Shares withheld for taxes | −9,057 | $1.89 | $17K | 1,074,934 |
| 2026-02-14 | Hirsch Andrew President & CEO | Option exercise | +81,725 | 1,123,145 | ||
| 2026-02-14 | Hirsch Andrew President & CEO | Shares withheld for taxes | −39,154 | $1.89 | $74K | 1,083,991 |
| 2026-02-13 | Hirsch Andrew President & CEO | Grant or award | +700,000 | 1,123,145 | ||
| 2025-02-15 | Hirsch Andrew President & CEO | Shares withheld for taxes | −9,370 | $3.18 | $30K | 423,145 |
| 2025-02-14 | Hirsch Andrew President & CEO | Grant or award | +223,500 | 445,362 | ||
| 2025-02-14 | Hirsch Andrew President & CEO | Shares withheld for taxes | −12,847 | $3.18 | $41K | 432,515 |
| 2025-02-14 | Hirsch Andrew President & CEO | Grant or award · Stock Option (Right to Buy) | +335,300 | 335,300 | ||
| 2024-11-07 | Hirsch Andrew President & CEO | Option exercise | +12,500 | 227,412 | ||
| 2024-11-07 | Hirsch Andrew President & CEO | Shares withheld for taxes | −5,550 | $6.04 | $34K | 221,862 |
| 2024-11-07 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −12,500 | 35,000 | ||
| 2024-09-16 | Hirsch Andrew President & CEO | Option exercise | +7,500 | 218,241 | ||
| 2024-09-16 | Hirsch Andrew President & CEO | Shares withheld for taxes | −3,329 | $6.36 | $21K | 214,912 |
| 2024-09-16 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −7,500 | 47,500 | ||
| 2024-02-15 | Hirsch Andrew President & CEO | Shares withheld for taxes | −6,560 | $7.90 | $52K | 210,741 |
| 2024-02-14 | Hirsch Andrew President & CEO | Grant or award | +103,400 | 217,301 | ||
| 2024-02-14 | Hirsch Andrew President & CEO | Grant or award · Stock Option (Right to Buy) | +465,500 | 465,500 | ||
| 2023-09-18 | Hirsch Andrew President & CEO | Grant or award · Stock Option (Right to Buy) | +489,600 | 489,600 | ||
| 2023-08-30 | Hirsch Andrew President & CEO | Option exercise | +7,500 | 116,106 |
Page 1 of 2 · 33 trades